Healthcare IT

Request for TOC Request for Sample
BUY NOW

Middle East and Africa AI in Bioinformatics Market – Industry Trends and Forecast to 2029

Healthcare IT | Published Report | Aug 2022 | MEA | 350 Pages | No of Tables: 84 | No of Figures: 39

Report Description

Middle East and Africa AI in Bioinformatics Market, By Offering (Software, Services and Others), Type (Machine Learning, Deep Learning and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others) - Industry Trends and Forecast to 2029.

Get Exclusive Sample Copy of this Report Here

Middle East and Africa AI in Bioinformatics Market Analysis and Size

The reduction in the genetic sequencing cost has enhanced the demand of the market. The rising healthcare expenditure for better health services is also attributed to the growth of the market. The major market players are highly focused on various service launches and service approvals during this crucial period. In addition, the growing demand for bioinformatics and increasing public-private sector funding for bioinformatics are also contributing to the rising demand in the market.

Get Exclusive Sample Copy of this Report Here

Get Exclusive Sample Copy of this Report Here

The Middle East and Africa AI in bioinformatics market are growing in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in R&D activity for launching novel services in the market. The increasing advancements in bioinformatics technology are further boosting market growth. However, the high cost of instrumentations and cybersecurity concerns in bioinformatics might hamper the growth of the Middle East and Africa AI in bioinformatics market in the forecast period.

Data Bridge Market Research analyses that the AI in bioinformatics market is expected to reach the value of USD 588.86 million by 2029, at a CAGR of 31.3% during the forecast period. “Services" accounts for the largest technology segment in the AI in bioinformatics market due to rapid developments in technological pathways to commercialize the use of handheld AI in bioinformatics. The AI in bioinformatics market report also covers pricing analysis, patent analysis, and technological advancements in depth.         

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Year

2020 (Customisable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Offering (Software, Services and Others), Type (Machine Learning, Deep Learning and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others)

Countries Covered

South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East & Africa

Market Players Covered

SOPHiA GENETICS, Biomax Informatics Inc., QIAGEN, NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific, Inc., Dassault Systèmes, SomaLogic Operating Co., Inc. and among others.

Market Definition

Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein and is particularly useful in comparing genes and other sequences in proteins and different sequences within an organism or between organisms, looking at the evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is.

Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding the biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.

  • In the coming future, important decisions related to bioinformatics, on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.

AI in Bioinformatics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

  • Growing demand for bioinformatics

As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research, which involves biologists who learn programming, computer programmers, mathematicians, or database managers to learn the foundations of biology.

  • Reduction in the genetic sequencing cost

The strong demand for decreasing the cost of genomics and biomarker prediction has contributed to the creation of high-throughput genome sequencing, which often goes by the name next-generation sequencing (NGS). Thousands or millions of sequences in a single bioinformatics cycle are generated simultaneously. Dramatic upgrades to industrial NGS technologies have culminated in dramatic cutbacks in DNA sequencing cost-per-base. Thus recently, the main sequencing techniques have become the key subject of research, with sample design optimization taking a secondary function.

  • Increasing public-private sector funding for bioinformatics

In order to improve the workflow for bioinformatics, the federal agencies, the public, and the private agencies are providing funds in order to carry out bioinformatics projects and to scientists for research purposes. It is important to approach possible funders with a clear proposal and strategy of what is to be achieved in terms of bioinformatics capacity building in the institution as well as the intended outputs and outcomes. Many government bodies and private organizations across the globe are increasingly investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which, in turn, have improved the quality of these services.

  • High cost of instrumentation

The cost of the device plays a major factor in the market. The AI based bioinformatics instrument is highly sophisticated and needs high validation and other specification, which increase. Genomics instruments are also equipped with advanced features and functionalities and are thus priced at a premium, ranging between ~USD 10–20 million. As pharmaceutical companies and research laboratories require many such systems, their capital expenditure on procuring multiple genomic instruments is very high. In the case of small and medium-sized pharmaceutical companies and research laboratories, it is not feasible for them to make such high investments in multiple genomics instruments. Hence, the high cost of AI based equipment is expected to restrain the market growth.

  • Strategic initiatives of key players

The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by key market players. They are taking initiatives such as product launches, collaborations, mergers, acquisitions, and many more over the years and are expected to lead and create more opportunities in the market.

By successfully working with new technology firms to ensure continued growth, creativity, and viability in the industry, healthcare product suppliers have a huge opportunity. Health enterprises that implement technology-enabled technologies will explore new modes of goods for patient care, streamline processes and engage patients more.

Companies discover and develop advanced bioinformatics products, and these companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.

  • Advancement in bioinformatics technology

The dimensions and cost of bioinformatics platforms and instruments are decreasing, allowing easier uptake by public health laboratories. Although currently, AI based bioinformatics requires highly specialized equipment and substantially skilled staff to analyze the data, it is unlikely that the bioinformatics revolution has finished. With rising technology up-gradation of instruments and techniques is also needed, moreover, the bioinformatics market has a vast potential to upgrade in various applications, and there are high chances in the advancement of bioinformatics techniques in the forecasted period.

  • Lack of skilled professionals to perform AI based bioinformatics technology

One of biology's most rapidly developing fields of study is bioinformatics, which involves the development and use of computational tools for the collection, archiving, organisation, analysis, and visualisation of biological data. The advancement of technology has made it possible to reach the level of next-generation analysis from conventional data analysis methods. The advancement of the technology of bioinformatics requires various skill sets for its handling. As the bioinformatics platforms are highly automated and costly machines, the improper handling of such machines can damage their parts which can hamper achieving analysis and visualisation of biological data. Thereby, it will proportionally hamper the result of data processing. The dearth of skilled professionals having adequate skills and knowledge to perform next-generation sequencing, therefore, hampers the growth of the market.

Post COVID-19 Impact on AI in Bioinformatics Market

During the pandemic, the North bioinformatics sector is one that focuses on using a combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential when it comes to providing essential support to many areas of scientific research. The tools that bioinformatics can provide allow scientists to get to grips with larger data sets to mine and analyses them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.

The growth of the AI in bioinformatics market is increasing with the growing demand for analysis tools in drug discovery and development and the integration of AI in various fields to interpret the data more conveniently. Hence, the market is expected to grow significantly in the forecast period, whereas the cost and the complexity of AI integration may hamper the market growth. The intervention of COVID-19 has increased the R&D activities, which in turn positively add to the market growth.

Recent Developments

  • In June 2022, SOPHiA GENETICS, a leader in data-driven medicine, announced from the ESHG Conference in Vienna that it has achieved CE-IVD certification for the analytical functionality supported by its cloud-based SOPHiA DDM™ Platform, an accessory to diagnostic applications. With this certification, the SOPHiA DDM™ Platform is now IVD-ready to support all applications and modules designed for diagnostic purposes in the European Union and other markets recognizing this certification. This has helped the company to increase its Middle East and Africa presence in the market.
  • In December 2021, JADBio and BioLizard announced their partnership. BioLizard is agile bioinformatics and AI/ML company Middle East and Africa, servicing clients in the life sciences, biotechnology, and pharmaceutical industries. JADBio is a robust Automated Machine Learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data while allowing for knowledge (biomarker signature) discovery through its vast range of reporting and analysis. This has helped the company to expand its products and services portfolio in the market.

Middle East and Africa AI in Bioinformatics Market Scope

Middle East and Africa AI in bioinformatics market are segmented on the basis of offering, type, products and services, application, and sector. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Offering

  • Services
  •  Software
  •  Others

On the basis of offering, the Middle East and Africa AI in bioinformatics market is segmented into services, software, and others.

Type

  • Machine Learning
  • Deep Learning
  • Others

On the basis of type, the Middle East and Africa AI in bioinformatics market has been segmented into machine learning, deep learning, and others.

Products and Services

  • Bioinformatics Services
  • Bioinformatics Platforms
  • Knowledge Management Tools

On the basis of products and services, the Middle East and Africa AI in bioinformatics market has been segmented into bioinformatics services, bioinformatics platforms, and knowledge management tools.

Application

  • Genomics
  • Chemoinformatics & Drug Design
  • Proteomics
  • DNA Sequencing
  • System Biology
  • Transcriptomics
  • Text Mining
  • Microarrays
  • Metabolomics
  • Others

On the basis of application, the Middle East and Africa AI in bioinformatics market has been segmented into below genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics and others.

Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Others

Get Exclusive Sample Copy of this Report Here

On the basis of sector, the Middle East and Africa AI in bioinformatics market has been segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others.

AI in Bioinformatics Market Regional Analysis/Insights

The AI in bioinformatics market is analysed, and market size insights and trends are provided by country, offering, type, products and services, application, and the sector as referenced South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East (MEA) as a part of the Middle East and Africa (MEA). South Africa is expected to dominate the Middle East and Africa AI in bioinformatics market due to rising research and development expenditure and the demand of advanced computational analysis tools to analysis the studies.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and AI in Bioinformatics Market Share Analysis

The AI in bioinformatics market competitive landscape provides details about the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, and product width and breadth, application dominance. The above data points provided are only related to the companies focus on the AI in bioinformatics market.

Some of the major players operating in the AI in bioinformatics market are SOPHiA GENETICS, Biomax Informatics Inc., QIAGEN, NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermofisher Scientific, Inc., Dassault Systèmes, SomaLogic Operating Co., Inc. among others.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 OFFERING LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET SECTOR COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST

5.1.2 GROWING DEMAND FOR BIOINFORMATICS

5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

5.2 RESTRAINTS

5.2.1 HIGH COST OF INSTRUMENTATION

5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS

5.3 OPPORTUNITIES

5.3.1 RISE IN HEALTHCARE EXPENDITURE

5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS

5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY

5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB

6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING

6.1 OVERVIEW

6.2 SERVICES

6.3 SOFTWARE

6.4 OTHERS

7 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 MACHINE LEARNING

7.3 DEEP LEARNING

7.4 OTHERS

8 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES

8.1 OVERVIEW

8.2 BIOINFORMATICS SERVICES

8.2.1 DATA ANALYSIS

8.2.2 SEQUENCING SERVICES

8.2.3 DATABASE MANAGEMENT

8.2.4 OTHERS

8.3 BIOINFORMATICS PLATFORMS

8.3.1 SEQUENCE ANALYSIS PLATFORMS

8.3.2 SEQUENCE ALIGNMENT PLATFORMS

8.3.3 STRUCTURAL ANALYSIS PLATFORMS

8.3.4 SEQUENCE MANIPULATION PLATFORMS

8.3.5 OTHERS

8.4 KNOWLEDGE MANAGEMENT TOOLS

8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

9 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS

9.3 CHEMOINFORMATICS & DRUG DESIGN

9.4 PROTEOMICS

9.5 DNA SEQUENCING

9.6 SYSTEM BIOLOGY

9.7 TRANSCRIPTOMICS

9.8 TEXT MINING

9.9 MICROARRAYS

9.1 METABOLOMICS

9.11 OTHERS

10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR

10.1 OVERVIEW

10.2 MEDICAL BIOTECHNOLOGY

10.3 ANIMAL BIOTECHNOLOGY

10.4 PLANT BIOTECHNOLOGY

10.5 ENVIRONMENTAL BIOTECHNOLOGY

10.6 FORENSIC BIOTECHNOLOGY

10.7 OTHERS

11 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY REGION

11.1 MIDDLE EAST AND AFRICA

11.1.1 SOUTH AFRICA

11.1.2 ISRAEL

11.1.3 SAUDI ARABIA

11.1.4 U.A.E

11.1.5 EGYPT

11.1.6 REST OF MIDDLE EAST AND AFRICA

12 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 ILLUMINA, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 DASSAULT SYSTEMES

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 EUROFINS SCIENTIFIC

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 THERMO FISHER SCIENTIFIC INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 QIAGEN

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENTS

14.6 SOPHIA GENETICS

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 ARDIGEN

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 BIOMAX INFORMATICS AG

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 CELBRIDGESCIENCE.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 DNASTAR

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 ELUCIDATA

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 FIOS GENOMICS

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 INDX. AI.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 INSILICO MEDICINE

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 JADBIO & GNOSIS DATA ANALYSIS

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 NEOGENOMICS LABORATORIES

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENTS

14.17 PAIGE AI, INC.

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 SOMALOGIC OPERATING CO., INC.

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENTS

14.19 SOURCE BIOSCIENCE.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STRAND LIFE SCIENCES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 BIOINFORMATICS COST PER SAMPLE

TABLE 2 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA SERVICES IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA SOFTWARE IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA MACHINE LEARNING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA DEEP LEARNING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA GENOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA CHEMOINFORMATICS & DRUG DESIGN IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PROTEOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA DNA SEQUENCING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA SYSTEM BIOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA TRANSCRIPTOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA TEXT MINING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA MICROARRAYS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA METABOLOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA MEDICAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA PLANT BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA ENVIRONMENTAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA FORENSIC BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA OFFSITE STERILIZATION SERVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 44 SOUTH AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 45 SOUTH AFRICA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 SOUTH AFRICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 47 SOUTH AFRICA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 48 SOUTH AFRICA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 49 SOUTH AFRICA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 50 SOUTH AFRICA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 51 SOUTH AFRICA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 52 ISRAEL AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 53 ISRAEL AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 ISRAEL AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 55 ISRAEL BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 56 ISRAEL BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 57 ISRAEL KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 58 ISRAEL AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 59 ISRAEL AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 60 SAUDI ARABIA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 61 SAUDI ARABIA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 SAUDI ARABIA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 63 SAUDI ARABIA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 64 SAUDI ARABIA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 65 SAUDI ARABIA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 66 SAUDI ARABIA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 SAUDI ARABIA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 68 U.A.E AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 69 U.A.E AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 U.A.E AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 71 U.A.E BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 72 U.A.E BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 73 U.A.E KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 74 U.A.E AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 U.A.E AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 76 EGYPT AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 77 EGYPT AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 EGYPT AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 79 EGYPT BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 80 EGYPT BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 81 EGYPT KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 82 EGYPT AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 83 EGYPT AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 84 REST OF MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST & AFRICA AI IN BIOINFORMATICSMARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID

FIGURE 9 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 11 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD

FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET

FIGURE 14 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021

FIGURE 15 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)

FIGURE 17 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 19 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021

FIGURE 23 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)

FIGURE 25 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 27 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 29 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 31 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 33 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 35 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 36 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)

FIGURE 39 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

View Infographics

FIGURE 1 MIDDLE EAST & AFRICA AI IN BIOINFORMATICSMARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID

FIGURE 9 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 11 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD

FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET

FIGURE 14 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021

FIGURE 15 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)

FIGURE 17 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 19 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021

FIGURE 23 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)

FIGURE 25 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 27 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 29 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 31 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 33 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 35 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 36 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 MIDDLE EAST AND AFRICA AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)

FIGURE 39 MIDDLE EAST & AFRICA AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19